Updated:
GMO
GMO is a global investment management firm co-founded by Jeremy Grantham in 1977. The firm offers strategies including asset allocation, global equities,...
GMO
GMO is a global investment management firm co-founded by Jeremy Grantham in 1977. The firm offers strategies including asset allocation, global equities, quality strategies, and focused equity. GMO operates across the Americas, Europe, Middle East, Africa, Asia, and Australia/New Zealand.
General information
Firm type
Asset Manager
Year founded
1977
AUM
$65B USD (per the firm, 2024)
Location
Region
North America
Country
United States
City
Singapore
Corporate office
Boston, MA, United States
Additional offices
Mountain View, CA, United States · Wilmington, DE, United States · Dubai, United Arab Emirates
Principals
Jeremy Grantham
Co-Founder and Long-Term Investment Strategist
Ben Inker
Co-Head of Asset Allocation
Tom Hancock
Co-Head of Asset Allocation
Ted Darling
Chief Executive Officer
Sector focus
Frequently asked questions
Who manages investment decisions at GMO?
GMO's investment decisions are led by a team of portfolio managers, with Ben Inker and Tom Hancock co-heading asset allocation. Jeremy Grantham serves as Long-Term Investment Strategist, providing macro commentary. The firm's quantitative models are designed by a large research team, with oversight from the investment committee.
How does GMO source investment ideas and generate returns?
GMO uses a proprietary quantitative framework that screens global markets for value, quality, and sentiment anomalies. Ideas emerge from systematic models rather than discretionary stock-picking, with the firm's edge in long-term horizon analysis and contrarian positioning. The approach has been publicly detailed in white papers and commentary (per the firm).
How is GMO related to Jeremy Grantham's environmental philanthropy?
Jeremy Grantham co-founded the Grantham Foundation for the Protection of the Environment, separate from GMO. The foundation supports climate and biodiversity initiatives, with Grantham's philanthropic identity distinct from his role at GMO. The two entities operate independently.
Does GMO explicitly avoid certain sectors or strategies?
GMO avoids high-growth, low-quality, and heavily speculative sectors, particularly those trading at extreme valuations. It has historically steered away from technology stocks during bubble periods, and generally does not invest in private markets, commodities, or currencies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: